Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400088387Phase 4Not yet recruiting
Phase 4 trial of remimazolam and propofol in hypopnea (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Incidence of desaturation. Planned start Aug 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400088387.